Numan Unees is the first MS patient in Sheffield to trial a new immunotherapy treatment.

Treatment with stem cells is safe and shows signs of slowing brain atrophy in people with progressive MS, per long-term early study data.

Scientists hunting for treatments and cures for multiple sclerosis may have found an unlikely ally — the yak. The high-altitude, cold-hardy relative of the cow could be the key to a medical ...

Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression. In recent years, the management of multiple ...

MS is a chronic, immune-mediated disease affecting the central nervous system, with no known cure and varying levels of impact on individuals. Over 20 FDA-approved disease-modifying therapies exist, ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine suggests that a therapy called Tolebrutinib could reduce disability progression in ...

CHARLOTTE, N.C. — There was a time when experts doubted the existence of a multiple sclerosis (MS) prodrome. But over the past decade, it has become a widely recognized and increasingly studied ...

Researchers are using lab-grown “mini brains” to investigate ways to repair myelin, the coating around nerve cells that is ...

Stem cells are sometimes seen as either controversial or lifesaving, depending on what they are being used for, but a new breakthrough in the treatment of multiple sclerosis (MS) has researchers and ...

Modern therapies have transformed care for people with multiple sclerosis (MS). Yet the disease continues to progress in a ...

Zeposia (ozanimod) is a prescription drug used to treat certain forms of multiple sclerosis (MS) in adults. Zeposia is a brand-name drug and is not currently available in a generic version. Zeposia ...